medigraphic.com

2012, Número 3

AMC 2012; 16 (3)


Cómo evaluar un paciente con miotonía

Herrera LOA

Idioma: Español
Referencias bibliográficas: 38
Paginas: 353-368
Archivo PDF: 148.69 Kb.


RESUMEN

Introducción: la miotonía es un desorden del músculo, caracterizado por una relajación demorada del músculo esquelético después de la contracción voluntaria o por efecto de la percusión.
Desarrollo: se comenta la fisiopatología a la luz de los conocimientos actuales en relación a los defectos genéticos ligados a las canalopatías. Se discute el diagnóstico positivo y diferencial, la clasificación, las principales formas clínicas y el tratamiento.
Conclusiones: a pesar de un conocimiento creciente de la base genética de estos desórdenes, los rasgos clínicos y el electro diagnóstico permanecen como aliados insuperables en el diagnóstico positivo y diferencial de las mismas. Sobre las miotonías no distróficas existen algunas respuestas, con muchas más interrogantes tanto en su reconocimiento clínico como en su clasificación y tratamiento.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Meola G, Moxley RT. Myotonic dystrophy type 2 and related myotonic disorders. J eurol. 2004; 251:1173-82.

  2. Machuca-Tzili L, Brook D, Hilton-Jones D. Clinical and molecular aspects of the myotonic dystrophies: a review. Muscle Nerve. 2005; 32:1-18.

  3. Meola G, Sansone V, Marinou K, Cotelli M, Moxley RT, Thornton CA, et al. Proximal myotonic myopathy: a syndrome with a favourable prognosis? J Neurol Sci. 2002; 193:89-96

  4. Day JW, Ricker K, Jacobsen JF, Rasmussen LJ, Dick A, Kress W. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology. 2003; 60:657-64.

  5. Heatwole CR, Moxley RT. The Nondystrophic Myotonias.Neurotherapeutics. 2007; 4:238-51.

  6. Raja Rayan DL, Hanna MG. Skeletal muscle channelopathies: nondystrophic myotonias and periodic paralysis. Curr Opin Neurol. 2010 Oct; 23(5):466-76.

  7. Lehmann Horn F, Jurkat Rott K, Rudel R. Diagnostics and Therapy of Muscle Channelopathies - Guidelines of the Ulm Muscle Centre. Acta Myol. 2008 December; 27(3):98-113.

  8. Ryan AM, Matthews E, Hanna MG. Skeletal-muscle channelopathies: periodic paralysis and nondystrophic myotonias. Curr Opin Neurol. 2007 Oct; 20(5):558-63.

  9. Lehmann-Horn F, Rudel R, Jurkat-Rott K. Nondystrophic myotonias and periodic paralyses. 3rd edition. New York: McGraw-Hill; 2004.

  10. Udd B, Meola G, Krahe R, Thornton C, Ranum LP, Bassez G, et al. ENMC International Workshop: Myotonic Dystrophy DM2/PROMM and other myotonic dystrophies with guidelines on management. Neuromuscul Disord. 2006; 16:403-13.

  11. Mankodi A. Myotonic disorders. Neurology India. 2008; 56(3):298-304.

  12. Shapiro B, Ruff R. Disorders of skeletal muscle membrane excitability: myotonia congenita, paramyotonia congenita, periodic paralysis,and related disorders. In: Katirji B, Kaminski HJ, Preston DC, Ruff RL, Shapiro BE, editors. Neuromuscular disorders in clinical practice. Boston: Butterworth-Heinemann; 2002.p.987-1020.

  13. Adams R, Victor M. Disorders of muscle characterized by cramp, spam, pain, and localized masses. In: Adams R, Victor M, editors. Principios de Neurología. 6ta Ed. Boston: Mc Graw Hill Interamericana. 2005.p.1276-84.

  14. Coers C, Teleman Toppet N, Durda J. Neurogenic benign fasciculations, pseudomyotonia, and pseudotetany. Arch Neurol.1981;38:282-4.

  15. Isaacs H. Continuous muscle fibre activity in an Indian male with additional evidence of terminal motor fibre abnormality. J Neurol Neurosurg Psychiatry.1967; 30:126-30.

  16. Brooke MH. Disorders of skeletal muscle. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD, editors. Neurology in clinical practice. 3rd ed. Boston: Butterworth-Heinemann; 2003.p.2187-223.

  17. Fischer D, Schroder R. Isaacs' syndrome. Diagnosis and differential diagnosis of neuromyotonia. Nervenarzt. 2004 Jun; 75(6):531-5.

  18. Gonzalez G, Barros G, Russi ME, Nuñez A, Scavone C. Acquired neuromyotonia in childhood: case report and review. Pediatr Neurol. 2008 Jan; 38(1):61-3.

  19. Moersch FP, Woltman HW. Progressive fluctuating muscular rigidity (stiff-man syndrome): Report of a case and some observations in 13 other cases. Mayo Clin Proc.1956; 31:421-3.

  20. Raju R, Hampe CS. Immunobiology of stiff-person syndrome. Int Rev Immunol. 2008; 27:79-92.

  21. Piróg KA, Briggs MD. Skeletal Dysplasias Associated with Mild Myopathy A Clinical and Molecular Review. J Biomed Biotechnol. 2010 May; 24(10):11-55.

  22. Kulkarni ML, Rajappan P. Schwartz-Jampel Syndrome. Indian Pediatrics. 2004;2:285.

  23. Voermans NC, Bonnemann CG, Huijing PA. Clinical and molecular overlap between myopathies and inherited connective tissue diseases. NeuromuscularDisorders. 2008; 18(11):843-56.

  24. Harper P. Myotonic dystrophy: a multisystemic disorder. In: Harper P, Van Engelen B, Eymard B, editors. Myotonic dystrophy: present management, future therapy. Oxford: Oxford University Press; 2004.p.3-13.

  25. Lossin C, George AL. Myotonia congenita. Adv Genet. 2008; 63(2):25-55.

  26. Colding Jorgensen E. Phenotypic variability in Myotonia Congenita. Muscle Nerve. 2005; 32(3):19-34.

  27. Cherian A, Neeraj N, Kuruvilla A. Muscle channelopathies and electrophysiological approach. Ann Indian Acad Neurol. 2008 Jan-Mar; 11(1):20-7.

  28. Fournier E, Arzel M, Sternberg D, Vicart S, Laforet P, Eymard B, et al. Electromyography guides toward subgroups of mutations in muscle channelopathies. Ann Neurol. 2004; 56:650-61.

  29. Amato AA, Dumitru D. Hereditary myopathies. In: Dumitru D, Amato AA, Zwarts MJ, editors. Electrodiagnostic medicine. 2nd ed. Philadelphia: Hanley and Belfus; 2002.p.1265-1370.

  30. Vicart S, Sternberg D, Fontaine B, Meola G. Human skeletal muscle sodium channelopathies. Neurol Sci. 2005 Oct; 26(4):194-202.

  31. Platt D, Griggs R. Skeletal Muscle Channelopathies: New insights into the periodic paralyses and nondystrophic myotonias. Curr Opin Neurol. 2009 Oct; 22(5):524-31.

  32. Fournier E, Viala K, Gervais H, Sternberg D, Arzel-Hezode M, Laforet P, et al. Cold extends electromyography distinction between ion channel mutations causing myotonia. Ann Neurol. 2006 Sept; 60(3):356-65.

  33. Ricker K, Moxley RT, Heine R, Lehmann-Horn F. Myotonia fluctuans: a third type of muscle sodium channel disease. Arch Neurol. 1994; 51:1095-1102.

  34. Colding Jorgensen E, Duno M, Vissing J. Autosomal dominant monosymptomatic myotonia permanens. Neurology. 2006; 67:153-5.

  35. Kubota T, Kinoshita M, Sasaki R, Aoike F, Takahashi MP, Sakoda S, et al. New mutation of the Na channel in the severe form of potassium-aggravated myotonia. Muscle Nerve. 2009 May; 39(5):666-73.

  36. Ptacek LJ, Tawil R, Griggs RC. Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysis. Neurology. 1994;44:1500-05.

  37. Venance SL, Cannon SC, Fialho D, Fontaine B, Hanna MG, Ptacek LJ, et al. The primary periodic paralyses: diagnosis, pathogenesis and treatment. Brain. 2006 Jan; 129(Pt 1):8-17.

  38. Moxley RT, Tawil R. Channelopathies: myotonic disorders and periodic paralysis. In: Swaiman KF, Ashwal S, Ferriero DM, editors. Pediatric neurology: principles and practice. 4th ed. Philadelphia: Mosby; 2006.p.2085-2109.




2020     |     www.medigraphic.com